- Every 4 minutes in the U.S., a patient loses a limb due to diabetes complications
- Black Americans face diabetes-related amputations 2x as often as white Americans
- Podimetrics strives to reduce disparities in diabetes care and unnecessary limb loss
SOMERVILLE, Mass., March 24, 2022 — Podimetrics, creator of the FDA-cleared SmartMat™ and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes, today announced a $45 million Series C round led by D1 Capital Partners, along with two new investors, the Medtech Convergence Fund and an undisclosed strategic investor. Existing investors, Polaris Partners and Scientific Health Development, also participated in the financing. Prior to Podimetrics’ Series C funding, they had raised $28.3 million in funding to fuel development and distribution of their SmartMat.
With this latest…